Radiopharm Theranostics Receives FDA IND Approval for Phase 2b Imaging Trial in Brain Metastases Biotech Investing
$12M Proposed Cash Asset Sale to Strengthen Balance Sheet, with $2.2M of Earn Outs Psychedelics Investing
Principal Technologies Announces Extension of Private Placement Closing Date Pharmaceutical Investing
